Clinical applicability of diagnostic biomarkers in early-onset cognitive impairment.
Neus FalgàsAdrià Tort-MerinoMircea BalasaSergi BorregoM CastellvíJaume OlivesBeatriz BoschG Férnandez-VillullasAnna AntonellJosep Maria AugeF LomeñaAndrés PerissinottiNuria BargalloRaquel Sanchez-ValleAlbert LladóPublished in: European journal of neurology (2019)
Biomarker procedures are well tolerated and have an important diagnostic/therapeutic impact on early-onset cognitive impairment.